Look into my eyes. What do you see? the man says to his wife.
I see Parkinsons, Alzheimers and MS, she replies.
Not the most romantic interchange.
But imagine if gazing into someones eyes were the key to diagnosing neurological disorders, which are the worlds leading cause of disabilityand cost some $800 billion a year in direct treatment expenses.
The correlations between oculometrics (the biometric measurement of the movement and condition of the eyes) and neurological conditions is a much-researched area of study, with over 750 papers published in journals such as The Lancet, Nature and Neurology.
Developing a technology that can decode the data from the eyes has proven to be challenging, however. No one has successfully made strides toward commercializing an oculometric approach.
Until now.
In October 2021, Tel Aviv and Austin, Texas-based startup Neuralight launched out of stealth with a $5.5 million seed investment and a goal of digitizing and even automating neurological evaluation and care.
You can only improve what you can measure
Neurological exams have traditionally relied on a subjective, manual assessment of symptoms.
The physician will ask 50 questions, like how hard is it to button your shirt? Or the doctor asks the patient to walk across the room so they can assess their gait, explains Neuralight CEO Micah Breakstone.
The lack of objective criteria has prevented pharmaceutical companies from developing effective drugs. Breakstone notes that for dementia, studies have shown that two physicians looking at the same patient on the same day could have a 35 percent variable in diagnosis.
We need a statistically significant result, Breakstone says.
Neuralights technology is not a cure or a treatment for neurological disease.
Rather, the platform is meant mainly to accelerate pharmaceutical development, with an initial focus on Parkinsons, Alzheimers and multiple sclerosis.
The platform automatically extracts microscopic eye movement measurements that serve as digital endpoints for neurological disorders.
A physician will record a short, five-minute video of a patients eyes. Neuralights imaging tools clean up the video, then artificial intelligence and machine learning get to work at deciphering whats behind the eye movements.
Once Neuralight has extracted ocular metrics on a patient, it plans to sell the data to pharma companies. As Breakstone tells ISRAEL21c, You cant improve what you dont measure.
Digital endpoints are the future of neurology, adds Rivka Kreitman, the companys chief innovation officer and the former head of global innovative research and development at Israeli pharmaceutical giant Teva.
This technology has been the missing piece pharma has needed to make drug development for neurological diseases effective and ultimately more successful.
Privacy compliant
In Breakstones ideal world, all the data extracted from videos by Neuralight would be processed on the Neuralight cloud, which he says is HIPAA compliant with all data de-identified (We dont need to see a patients face, only his or her eyes).
Some organizations do want to keep the data in-house for privacy reasons; in those cases, Neuralight brings its own server.
Neuralight does not require eye-trackers, making the process simpler for patients because they dont have to sit still for a relatively long period of time.
Instead, a simple iPhone or even Zoom recording is fine. A Neuralight video recording takes 10 minutes vs. 40 minutes when working with an eye-tracker.
Neuralights AI amplifies and augments standard video resolution so you can glean from standard video signals what you could traditionally do only with professional lab equipment, Breakstone explains.
He likens the resolution to how satellites in space can make out the numbers on a cars license plate using a similar kind of super-resolution.
Neuralight analyzes close to 100 parameters, including blinking rate, how quickly the patient can fix on a specific object, and the speed of pupil dilation (the latter is highly correlated with Parkinsons).
Digital biomarkers
Breakstone cofounded Neuralight with CTO Edmund Benami after Breakstone sold his previous startup, Chorus.ai, to ZoomInfo for $575 million.
I could have retired, but that would have been a little empty, he says. His grandfather suffered from Alzheimers, and that led Breakstone to want to do something to make the world a better place, something I deeply believed in, he tells ISRAEL21c.
Digital biomarkers are very much in vogue, he says, and investors agreed.
Initial funding for Neuralight came from VSC Ventures, Operator Partners, Clover Health CEO Vivek Garipalli and Noam Solomon, the CEO of Immunai.
While most of the 19-person team is in Israel, where R&D is based, Breakstone relocated to Austin to build up the companys connections in the United States.
Neuralight has a working MVP (tech speak for minimum viable product) and Breakstone hopes to receive initial FDA clearance by the end of 2022 with the first commercial contracts signed in 2023.
Clinical trials are due to kick off in the next few months. Neuralight is in conversations with three large pharma companies.
Although neurotechnology is a booming industry, Breakstone says most of Neuralights competition is doing things with devices, not with the eyes. Boston-based Beacon Biosignals, for example, uses EEG data to create biomarkers for neurological disorders, which he says will be harder to be adopted as a universal solution.
Fortunately for the billion people suffering from neurological disorders, Breakstone feels that Neuralight is on an urgent mission. We are building a value-driven company.
For more on Neuralight, click here.
Produced in association with ISRAEL21c.
See the original post:
The Answer To Parkinson's And Alzheimer's Is All In Your Eyes - Themississippilink
- Neurotechnology - Wikipedia, the free encyclopedia [Last Updated On: June 17th, 2016] [Originally Added On: June 17th, 2016]
- Biomimetic Underwater Robot Program [Last Updated On: June 21st, 2016] [Originally Added On: June 21st, 2016]
- SINAPSE - Singapore Institute for Neurotechnology [Last Updated On: July 25th, 2016] [Originally Added On: July 25th, 2016]
- Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) [Last Updated On: August 10th, 2016] [Originally Added On: August 10th, 2016]
- Neurotechnology SDK's | Developer tools for integrating ... [Last Updated On: October 17th, 2016] [Originally Added On: October 17th, 2016]
- Vaziri Lab | Laboratory of Neurotechnology and Biophysics [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- Neurotechnology - Wikipedia [Last Updated On: November 6th, 2016] [Originally Added On: November 6th, 2016]
- Neurotechnology Market Research and Data [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Neurotechnology and Society (20102060) - Lifeboat [Last Updated On: December 2nd, 2016] [Originally Added On: December 2nd, 2016]
- About Neurotechnology: company information and white paper [Last Updated On: January 14th, 2017] [Originally Added On: January 14th, 2017]
- UTMB Researchers Discover Reason for Permanent Vision Loss After Head Injury - Galveston.com & Company (press release) (blog) [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- Top 4 Underrated Technologies - The Merkle [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- SentiVeillance 5.0 software development kit (SDK) - Officer.com (press release) (registration) (blog) [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- Memristor Research Highlights Neuromorphic Device Future - The Next Platform [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Global Fingerprint Biometrics in the VAR Market 2016 Fulcrum Biometrics, Neurotechnology, 360 Biometrics ... - Albanian Times [Last Updated On: February 18th, 2017] [Originally Added On: February 18th, 2017]
- Israel and Indiana: Why You're Getting an Invitation to the Holy Land ... - 93.1 WIBC Indianapolis [Last Updated On: February 22nd, 2017] [Originally Added On: February 22nd, 2017]
- 3Q: US Patent Office's Ruling on CRISPR - Bioscience Technology [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- 5th Annual Big Idea Competition Nets Three Winners Colorado ... - Colorado College News [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- 7 reasons you must attend WIRED Health 2017 - Wired.co.uk [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- Edward Boyden | Big Think - Big Think [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- BioDirection to Participate in 12th World Congress on Brain Injury - Yahoo Finance [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- What Health Care Can Learn from Wal-Mart - Wall Street Journal (subscription) (blog) [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Stryker (NYSE:SYK) target price raised to $135.00, reported today ... - Breaking Finance News [Last Updated On: March 4th, 2017] [Originally Added On: March 4th, 2017]
- A report released today by RBC Capital Markets about Stryker Corporation (NYSE:SYK) ups the target price to $135.00 - Breaking Finance News [Last Updated On: March 4th, 2017] [Originally Added On: March 4th, 2017]
- How 'brain wearables' can address 21st century needs - IoT Tech News [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Stryker's AVAflex Vertebral Balloon System Receives FDA 510(k) Clearance - OrthoSpineNews [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Paralysis patients achieve fastest typing yet with new brain-computer interface - The Brown Daily Herald [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- RBC Capital Markets Boosts Stryker Co. (SYK) Price Target to $135.00 - Chaffey Breeze [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]
- Stryker's Spine Division To Feature Novel 3D-Printed Spinal Implants at AAOS Conference - OrthoSpineNews [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]
- Preview: MedX Future of Healthcare conference - The Mancunion [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - OrthoSpineNews [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- How to ensure future brain technologies will help and not harm society - USAPP American Politics and Policy (blog) [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year - Yahoo Finance [Last Updated On: March 12th, 2017] [Originally Added On: March 12th, 2017]
- This therapy may balance brain signals to reduce blood pressure, migraines - Knowridge Science Report [Last Updated On: March 17th, 2017] [Originally Added On: March 17th, 2017]
- Several tech billionaires are openly or secretely funding broadband mind computer interfacing projects - Next Big Future [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]
- New SentiVeillance 6.0 Improves Speed and Accuracy for Biometric Identification Using Surveillance Cameras - PR Newswire (press release) [Last Updated On: March 21st, 2017] [Originally Added On: March 21st, 2017]
- The FY2017 EPS Estimates for Stryker Co. (SYK) Increased by Leerink Swann - Petro Global News 24 [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- Congress introducing legislation ahead of AIPAC week Jewish ... - Jewish Journal [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- Senate resolution supports economic collaborations with Israel - The Albany Herald [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- Neurotechnology releases new SentiVeillance SDK - Biometric Update [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- 'Biggest Loser' Doctor Now Repped by Hulk's Winner - Courthouse News Service [Last Updated On: March 27th, 2017] [Originally Added On: March 27th, 2017]
- Stryker Co. (SYK) to Issue Quarterly Dividend of $0.43 on April 28th - Chaffey Breeze [Last Updated On: March 27th, 2017] [Originally Added On: March 27th, 2017]
- The Stryker Co. (SYK) to Issue Quarterly Dividend of $0.43 on April 28th - Petro Global News 24 [Last Updated On: March 29th, 2017] [Originally Added On: March 29th, 2017]
- Neurotechnology Releases New Cloud-based Biometric Time and Attendance Service, Updates NCheck Bio Attendance - PR Web (press release) [Last Updated On: March 29th, 2017] [Originally Added On: March 29th, 2017]
- Neurotechnology releases new biometric access solutions - Planet Biometrics [Last Updated On: March 29th, 2017] [Originally Added On: March 29th, 2017]
- Neurotechnology releases new biometric time and attendance products - Biometric Update [Last Updated On: March 29th, 2017] [Originally Added On: March 29th, 2017]
- Elon Musk wants to merge man and machine here's what he'll need to work out - The Conversation UK [Last Updated On: April 2nd, 2017] [Originally Added On: April 2nd, 2017]
- Elon Musk Wants to Merge Man and MachineHere's What He'll ... - Observer [Last Updated On: April 3rd, 2017] [Originally Added On: April 3rd, 2017]
- How Neurotechnology Is Helping The San Francisco Giants Train Better - PSFK (subscription) [Last Updated On: April 3rd, 2017] [Originally Added On: April 3rd, 2017]
- Synchron Inc. Secures $10 Million in Series A Financing Round - PR Newswire (press release) [Last Updated On: April 7th, 2017] [Originally Added On: April 7th, 2017]
- Brain, the last frontier! - Huffington Post [Last Updated On: April 12th, 2017] [Originally Added On: April 12th, 2017]
- Analyst Activity Jefferies Group LLC Reiterates Hold on Stryker (NYSE:SYK) - Market Exclusive [Last Updated On: April 15th, 2017] [Originally Added On: April 15th, 2017]
- Academia, industry collaborate on solutions to neural disease, injury - Medical Xpress [Last Updated On: April 19th, 2017] [Originally Added On: April 19th, 2017]
- Reduction of Post -Traumatic Stress Symptoms Associated with Non-Invasive Neurotechnology - Newswise (press release) [Last Updated On: April 19th, 2017] [Originally Added On: April 19th, 2017]
- Academia, Industry Collaborate on Solutions to Neural Disease, Injury - Texas Medical Center (press release) [Last Updated On: April 25th, 2017] [Originally Added On: April 25th, 2017]
- Stryker Co. Announces Quarterly Dividend of $0.43 (SYK) - The Cerbat Gem [Last Updated On: April 25th, 2017] [Originally Added On: April 25th, 2017]
- PTSD Symptoms May Be Eased by Non-Invasive Neurotechnology - Psychiatry Advisor [Last Updated On: April 25th, 2017] [Originally Added On: April 25th, 2017]
- A new category of human rights: neurorights - BMC Blogs Network (blog) [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- In a neuro-techno future, human rights laws will need to be revisited - Science Daily [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- New computers could delete thoughts without your knowledge ... - The Independent [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- Rise of Neurotechnology: Defend Against Brain Hackers Before It's Too Late - Sputnik International [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- Download - Neurotechnology [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- Researchers advocate neurorights to protect brain data - The Stack [Last Updated On: April 28th, 2017] [Originally Added On: April 28th, 2017]
- Will your computer delete your thoughts? - TRUNEWS [Last Updated On: April 28th, 2017] [Originally Added On: April 28th, 2017]
- Future tech could jeopardise 'freedom of mind', say experts - Daily News & Analysis [Last Updated On: April 30th, 2017] [Originally Added On: April 30th, 2017]
- This Is Your Brain on Business - Fortune [Last Updated On: May 2nd, 2017] [Originally Added On: May 2nd, 2017]
- Future tech could jeopardise 'freedom of mind': experts - Outlook India - Outlook India [Last Updated On: May 2nd, 2017] [Originally Added On: May 2nd, 2017]
- Do We Have a Right to Mental Privacy and Cognitive Liberty? - Scientific American (blog) [Last Updated On: May 4th, 2017] [Originally Added On: May 4th, 2017]
- Freedom of the mind under threat with new technology - BioEdge [Last Updated On: May 8th, 2017] [Originally Added On: May 8th, 2017]
- Rythm Accelerates Sleep Research and Neurotechnology Efforts With a Prestigious Scientific Advisory Board and ... - PR Newswire (press release) [Last Updated On: May 13th, 2017] [Originally Added On: May 13th, 2017]
- FAQ Neurotechnology Innovations Translator [Last Updated On: May 13th, 2017] [Originally Added On: May 13th, 2017]
- $20000 ONtrepreneurs Pitch Challenge Winner Announced - Canada NewsWire (press release) [Last Updated On: May 23rd, 2017] [Originally Added On: May 23rd, 2017]
- Stryker (SYK) Getting Positive News Coverage, Study Shows - Chaffey Breeze [Last Updated On: May 28th, 2017] [Originally Added On: May 28th, 2017]
- Somewhat Positive Press Coverage Likely to Impact Stryker (SYK) Stock Price - The Cerbat Gem [Last Updated On: June 1st, 2017] [Originally Added On: June 1st, 2017]
- The tiny cyborg dragonfly drones have taken flight - Mashable [Last Updated On: June 1st, 2017] [Originally Added On: June 1st, 2017]
- Scientists remotely move a mouse's whiskers with electrodes outside its brain - The Verge [Last Updated On: June 1st, 2017] [Originally Added On: June 1st, 2017]
- Stryker (SYK) Receives Media Impact Score of 0.15 - Chaffey Breeze [Last Updated On: June 3rd, 2017] [Originally Added On: June 3rd, 2017]
- Stryker (SYK) Earning Somewhat Favorable Media Coverage, Report Finds - Chaffey Breeze [Last Updated On: June 5th, 2017] [Originally Added On: June 5th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m investment - Scottish Legal News [Last Updated On: June 7th, 2017] [Originally Added On: June 7th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m (EUR) investment - Shoosmiths legal updates (press release) [Last Updated On: June 7th, 2017] [Originally Added On: June 7th, 2017]